Advertisement
HST vs RARE
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HST is a Hold and RARE is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
HST’s FA Score shows that 0 FA rating(s) are green whileRARE’s FA Score has 0 green FA rating(s).
- HST’s FA Score: 0 green, 5 red.
- RARE’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
HST’s TA Score shows that 4 TA indicator(s) are bullish while RARE’s TA Score has 5 bullish TA indicator(s).
- HST’s TA Score: 4 bullish, 4 bearish.
- RARE’s TA Score: 5 bullish, 5 bearish.
Price Growth
HST (@Real Estate Investment Trusts) experienced а +0.93% price change this week, while RARE (@Biotechnology) price change was -31.00% for the same time period.
The average weekly price growth across all stocks in the @Real Estate Investment Trusts industry was +0.56%. For the same industry, the average monthly price growth was +2.82%, and the average quarterly price growth was +3.62%.
The average weekly price growth across all stocks in the @Biotechnology industry was +2.69%. For the same industry, the average monthly price growth was +18.51%, and the average quarterly price growth was +31.06%.
Reported Earning Dates
HST is expected to report earnings on Oct 29, 2025.
RARE is expected to report earnings on Nov 04, 2025.
Industries' Descriptions
@Real Estate Investment Trusts (+0.56% weekly)A real estate investment trust (REIT) is a company any that owns, and in most cases, operates, income-producing real estate – ranging from office and apartment buildings to warehouses, hospitals, shopping centers, hotels and timberlands. Some REITs are involved in financing real estate. Equity REITs invest in and own properties, while mortgage REITs own and invest in property mortgages. REITs are required by law to pay out at least 90% of their annual taxable income (excluding capital gains) to shareholders in the form of dividends. Some REITs could be more cyclical than others; for example, when an economy is undergoing a recession, hotel REITs could be more vulnerable, compared to say healthcare REIT given that healthcare needs are less likely to depend on economic cycles. American Tower Corporation, Prologis, Inc. and Crown Castle International Corp are some of the biggest REIT companies in the U.S.
@Biotechnology (+2.69% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
| HST | RARE | HST / RARE | |
| Capitalization | 14.6B | 2.57B | 568% |
| EBITDA | 1.67B | -449.9M | -372% |
| Gain YTD | -4.252 | -35.346 | 12% |
| P/E Ratio | 19.91 | N/A | - |
| Revenue | 5.31B | 591M | 899% |
| Total Cash | 1.14B | 494M | 232% |
| Total Debt | 4.77B | 38.3M | 12,460% |
HST | RARE | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 8 | 51 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 50 Fair valued | 50 Fair valued | |
PROFIT vs RISK RATING 1..100 | 48 | 100 | |
SMR RATING 1..100 | 100 | 100 | |
PRICE GROWTH RATING 1..100 | 48 | 90 | |
P/E GROWTH RATING 1..100 | 100 | 100 | |
SEASONALITY SCORE 1..100 | n/a | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
HST's Valuation (50) in the Real Estate Investment Trusts industry is in the same range as RARE (50) in the Biotechnology industry. This means that HST’s stock grew similarly to RARE’s over the last 12 months.
HST's Profit vs Risk Rating (48) in the Real Estate Investment Trusts industry is somewhat better than the same rating for RARE (100) in the Biotechnology industry. This means that HST’s stock grew somewhat faster than RARE’s over the last 12 months.
HST's SMR Rating (100) in the Real Estate Investment Trusts industry is in the same range as RARE (100) in the Biotechnology industry. This means that HST’s stock grew similarly to RARE’s over the last 12 months.
HST's Price Growth Rating (48) in the Real Estate Investment Trusts industry is somewhat better than the same rating for RARE (90) in the Biotechnology industry. This means that HST’s stock grew somewhat faster than RARE’s over the last 12 months.
HST's P/E Growth Rating (100) in the Real Estate Investment Trusts industry is in the same range as RARE (100) in the Biotechnology industry. This means that HST’s stock grew similarly to RARE’s over the last 12 months.
| HST | RARE | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 77% | 1 day ago 88% |
| Stochastic ODDS (%) | 1 day ago 67% | 1 day ago 72% |
| Momentum ODDS (%) | 1 day ago 71% | 1 day ago 74% |
| MACD ODDS (%) | 1 day ago 69% | 1 day ago 79% |
| TrendWeek ODDS (%) | 1 day ago 69% | 1 day ago 79% |
| TrendMonth ODDS (%) | 1 day ago 68% | 1 day ago 83% |
| Advances ODDS (%) | 13 days ago 66% | 13 days ago 76% |
| Declines ODDS (%) | 1 day ago 61% | 1 day ago 80% |
| BollingerBands ODDS (%) | 1 day ago 59% | 1 day ago 79% |
| Aroon ODDS (%) | 1 day ago 57% | 1 day ago 74% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| XHYT | 34.81 | 0.03 | +0.07% |
| BondBloxx US HY Telecm Md Tech Sctr ETF | |||
| LCDS | 59.54 | N/A | N/A |
| JPMorgan Fundamental Data Sci Lg Cor ETF | |||
| IYE | 46.17 | -0.67 | -1.43% |
| iShares US Energy ETF | |||
| XSLV | 45.59 | -0.85 | -1.82% |
| Invesco S&P SmallCap Low Volatility ETF | |||
| BETH | 86.85 | -1.93 | -2.17% |
| ProShares Bitcoin&EtherMktCapWtdETF | |||
RARE and
Correlation & Price change
A.I.dvisor indicates that over the last year, RARE has been closely correlated with MREO. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is a high statistical probability that if RARE jumps, then MREO could also see price increases.
| Ticker / NAME | Correlation To RARE | 1D Price Change % | ||
|---|---|---|---|---|
| RARE | 100% | -6.94% | ||
| MREO - RARE | 66% Closely correlated | -0.58% | ||
| IONS - RARE | 49% Loosely correlated | -1.29% | ||
| DNLI - RARE | 48% Loosely correlated | -3.54% | ||
| SNDX - RARE | 47% Loosely correlated | -6.50% | ||
| VCYT - RARE | 46% Loosely correlated | -5.29% | ||
More | ||||